EnLyte Monotherapy Reduces Toxic Homocysteine in Patients With MTHFR Polymorphism: Breakthrough Study Shows Significant Reduction In Toxic Amino Acid Linked To Hundreds Of Diseases
29 juil. 2015 18h20 HE
|
JayMac Pharmaceuticals
SUNSET, La., July 29, 2015 (GLOBE NEWSWIRE) -- A new study shows patients with the MTHFR C677T/A1298C enzyme polymorphism significantly benefit from reduced B vitamin therapy, marketed under the...
New Study Shows Homocysteine Reduction Directly Correlates With Higher Remission Rates in Depression
29 juil. 2015 18h03 HE
|
JayMac Pharmaceuticals
SUNSET, La., July 29, 2015 (GLOBE NEWSWIRE) -- It has been common knowledge in the medical community that administering B9 (folates), B12, and B6 will lower homocysteine levels in the body. However,...
New Study Proves Homocysteine Theory of Depression: Lower Homocysteine, Achieve Higher Remission Rates in Major Depressive Disorder
29 juil. 2015 18h02 HE
|
JayMac Pharmaceuticals (EnLyte)
SUNSET, La., July 29, 2015 (GLOBE NEWSWIRE) -- Major Depressive Disorder (MDD) affects up to 25% of people and the literature is clear that previous standards of treatment fall short: only 30% of...
Breakthrough Depression Study Shows 42% Remission Rate With EnLyte
29 juil. 2015 18h00 HE
|
JayMac Pharmaceuticals
SUNSET, La., July 29, 2015 (GLOBE NEWSWIRE) -- A new study shows patients with Major Depressive Disorder and the MTHFR enzyme polymorphism significantly benefit from reduced B vitamin therapy,...
Makers of EnLyte Proud To Support Annual Meeting of the American Association of Nurse Practitioners
08 juin 2015 11h32 HE
|
JayMac Pharmaceuticals (EnLyte)
SUNSET, La., June 8, 2015 (GLOBE NEWSWIRE) -- The national meeting of the American Association of Nurse Practitioners begins June 9th in New Orleans, bringing together over 5,000 nurse practitioners...
JayMac Pharmaceuticals Honors National Infertility Awareness Week
20 avr. 2015 15h47 HE
|
JayMac Pharmaceuticals (EnLyte)
SUNSET, La., April 20, 2015 (GLOBE NEWSWIRE) -- According to Resolve, The National Infertility Association, infertility is defined as two or more recurrent miscarriages. Up to 20% of all pregnancies...
JayMac Pharmaceuticals Comments on Article: "Side Effects One of Leading Causes of Antidepressant Dropout"
13 mars 2015 13h14 HE
|
JayMac Pharmaceuticals (EnLyte)
SUNSET, La., March 13, 2015 (GLOBE NEWSWIRE) -- 1 in 10 people suffer from depression, and prescriptions for antidepressants have increased 400% in the past two decades; yet, the patient compliance...
Increasing Demand Calls For EnLyte Website Upgrade
05 mars 2015 18h07 HE
|
JayMac Pharmaceuticals (EnLyte)
SUNSET, LA., March 5, 2015 (GLOBE NEWSWIRE) -- Reflecting the heightened demand for its prescription folate product, EnLyte, JayMac Pharmaceuticals has launched the upgraded EnLyteRx.Com. The new look...